epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove BiDil
    isosorbide dinitrate/ hydralazine
  • remove Hyzaar
    losartan/ hydrochlorothiazide
  • remove Lutera
    levonorgestrel/ ethinyl estradiol

multicheck MultiCheck Results - 7 Interactions

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face BiDil (isosorbide dinitrate/ hydralazine) + Hyzaar (losartan/ hydrochlorothiazide)

Monitor/Modify Tx


hydralazine + hydrochlorothiazide

monitor BP: combo may incr. risk of severe hypotension (additive effects)

hydralazine + losartan

monitor BP: combo may incr. risk of severe hypotension (additive effects)

isosorbide dinitrate + hydrochlorothiazide

monitor BP: combo may incr. risk of hypotension (additive effects)

isosorbide dinitrate + losartan

monitor BP: combo may incr. risk of severe hypotension, including syncope (additive effects)

Smiley face Smiley face BiDil (isosorbide dinitrate/ hydralazine) + Lutera (levonorgestrel/ ethinyl estradiol)

Monitor/Modify Tx


hydralazine + ethinyl estradiol (contraceptive)

monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

Smiley face Smiley face Hyzaar (losartan/ hydrochlorothiazide) + Lutera (levonorgestrel/ ethinyl estradiol)

Monitor/Modify Tx


hydrochlorothiazide + ethinyl estradiol (contraceptive)

monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

losartan + ethinyl estradiol (contraceptive)

monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback Cookie Preferences
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information